Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioequivalence studies: single vs multiple dose.

V W Steinijans1, R Sauter, J H Jonkman

  • 1Department of Biometry, Byk Gulden Research Laboratories, Konstanz, Germany.

International Journal of Clinical Pharmacology, Therapy, and Toxicology
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The age and sex dynamics of heterosexual HIV transmission in Zambia: an HPTN 071 (PopART) phylogenetic and modelling study.

medRxiv : the preprint server for health sciences·2026
Same author

Stent-Assisted Angioplasty (SAA) at the Level of the Common Femoral Artery Bifurcation: Long-Term Outcomes.

Cardiovascular and interventional radiology·2020
Same author

Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels.

Clinical research in cardiology supplements·2019
Same author

Current insights into the German Lipoprotein Apheresis Registry (GLAR) - Almost 5 years on.

Atherosclerosis. Supplements·2017
Same author

Erratum to: The German Lipoprotein Apheresis Registry (GLAR) - almost 5 years on.

Clinical research in cardiology supplements·2017
Same author

Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels.

Journal of thrombosis and haemostasis : JTH·2017

This study compares single-dose versus multiple-dose bioequivalence studies for generic drugs. It highlights the importance of choosing the correct study type for accurate drug equivalence assessment.

Area of Science:

  • Pharmacokinetics
  • Pharmaceutical Sciences
  • Drug Regulatory Affairs

Background:

  • Generic drug substitution is increasing, making bioequivalence crucial.
  • International regulations mandate bioequivalence studies for generic drug approval.
  • The choice between single-dose and multiple-dose bioequivalence studies requires further discussion.

Purpose of the Study:

  • To compare the outcomes of single-dose and multiple-dose bioequivalence studies.
  • To determine appropriate pharmacokinetic characteristics for bioequivalence assessment.
  • To provide recommendations for regulatory guidelines.

Main Methods:

  • Comparative analysis of single- and multiple-dose bioequivalence study data.
  • Evaluation of pharmacokinetic parameters from studies conducted in the same subjects.

Related Experiment Videos

  • Review of existing international and national guidelines.

    • Main Results:

    • Single- and multiple-dose studies can yield different conclusions regarding bioequivalence.
    • Specific drug formulations, like sustained-release theophylline, may necessitate multiple-dose studies.
    • Pharmacokinetic data interpretation is critical for accurate bioequivalence determination.

    Conclusions:

    • The choice of bioequivalence study design (single vs. multiple dose) impacts study outcomes.
    • Multiple-dose studies may be more appropriate for certain drug formulations.
    • Standardized recommendations for study design are needed to ensure reliable generic drug evaluation.